Successfully gaining CE Mark and FDA approval in the highly regulated field of dermal fillers and medical treatments/devices for aesthetic indications requires expertly executed clinical trials, highly accurate data collection and analysis, and a thorough understanding of the application process. HPA brings an unmatched breadth of expertise guiding medical and biotechnology manufacturers through the end-to-end development process of products for aesthetic indications, with specific expertise in dermal fillers, facial sutures, lasers, and neurotoxins and other injectables.